November 23, 1999

An article published Nov. 19 about Baxter International Inc.'s agreement to purchase North American Vaccine Inc. of Columbia stated that North American Vaccine's chief executive officer, Randal Chase, would receive a bonus as a result of the sale. The article failed to note that under his compensation plan, Chase is entitled to a bonus only if North American Vaccine is sold for at least $20 a share. North American is being sold for $7 a share; therefore, a bonus for Chase is not guaranteed.

The Sun regrets the omission.

Pub Date: 11/23/99

Baltimore Sun Articles
Please note the green-lined linked article text has been applied commercially without any involvement from our newsroom editors, reporters or any other editorial staff.